prof. dr. mohd shahrir bin mohamed said

pensyarah perubatan

jabatan perubatan

 shahrir@ppukm.ukm.edu.my



   Kluster Kepakaran/ Cluster of Expertise :
  • Kesihatan dan Perubatan Termaju,



  •    Biografi/ Biography :

  • Profesor dan Pakar Perunding Kanan Perubatan Dalaman dan Rheumatologi Penyelidikan beliau berkisar di dalam bidang rheumatologi dari segi klinikal dan molekular.
    Professor and Senior Consultant of Rheumatology and Internal Medicine. Research evolved around all aspects of rheumatology clinically and molecular.

  • nor adzimah johdi , noraidatulakma abdullah , ying-xian goh, joanna ooi su min, nor azila muhammad azami , muhammad irfan abdul jalal , azmawati mohammed nawi, norfazilah ahmad , mohd rohaizat hassan, anita sulong, najma kori, petrick periyasamy, faisal hamid, norrafidah md sapuan, sheela bai pannir selvam, noriah hajib, norlaila mustafa, noor zetti zainol rashid, sharifah azura salleh, hamidah alias, mohd shahrir mohamed said, siti norlia othman, poh bee koon, faizal amri hamzah, shamsuriani md jamal, razman jarmin, hanita othman, khamsiah nawawi, hanafiah harunarashid, mohammad nizam mokhtar, wan rahiza wan mat, azwa shawani kamalul arifin, aisyatul najihah khuzaimi, nazihah abd jalal, norliza ismail, nurul ain mhd yusuf, andri dauni, wan ahmad faisal wan sallam, ahmad syafiq shafie, mohd arman kamaruddin, rahman jamal.  (2026).  risk factors for covid-19 symptom severity across clinical categories among hospitalised patients in kuala lumpur, malaysia: a prospective cohort study.  - bmj open.  1 - 13. 

     

    thomas prisila, ping seung ong, mohd shahrir mohamed said, asrul abdul wahab.  (2025).  matrix metalloproteinase-9 as a biomarker for diagnosis and monitor disease progression in psoriatic arthritis.  - mediterranean journal of rheumatology.  380 - 386. 

     

    aimi arsyida ar, ilham i, ahmad faiq sa’dan mz, firhan h, mahrunissa m, cheong xk, nor aizan aa, suraya a, khoo cs, rabani r, mohd shahrir ms.  (2025).  immune-mediated necrotising myopathy (imnm) mimicking myasthenia gravis: a diagnostic and therapeutic challenge.  - medicine and health.  39 - 39. 

     

    norsyafirah mohamed sallehuddin, mohd shahrir mohamed said, nik nuratiqah nik abeed, nor shuhaila shahril, noorul afidza muhammad, shiau li lim, andrea ban yu lin, boon hau ng, syahrul sazliyana shaharir.  (2025).  the prevalence and clinical profiling of rheumatoid arthritis associated interstitial lung disease (ra-ild) in a multicenter cohort.  - respirology.  183 - 184. 

     

    kelly sze fang num, azimatun noor aizuddin , syahnaz mohd hashim, mohd shahrir mohamed said .  (2025).  navigating interprofessional collaboration in diabetes care: a qualitative study of early-career health professionals in malaysian primary care clinics.  - plos one.  1 - 27. 

     

    nor adzimah johdi , noraidatulakma abdullah , ying-xian goh, joanna ooi su min, nor azila muhammad azami , muhammad irfan abdul jalal , azmawati mohammed nawi, norfazilah ahmad , mohd rohaizat hassan, anita sulong, najma kori, petrick periyasamy, faisal hamid, norrafidah md sapuan, sheela bai pannir selvam, noriah hajib, norlaila mustafa, noor zetti zainol rashid, sharifah azura salleh, hamidah alias, mohd shahrir mohamed said, siti norlia othman, poh bee koon, faizal amri hamzah, shamsuriani md jamal, razman jarmin, hanita othman, khamsiah nawawi, hanafiah harunarashid, mohammad nizam mokhtar, wan rahiza wan mat, azwa shawani kamalul arifin, aisyatul najihah khuzaimi, nazihah abd jalal, norliza ismail, nurul ain mhd yusuf, andri dauni, wan ahmad faisal wan sallam, ahmad syafiq shafie, mohd arman kamaruddin, rahman jamal.  (2026).  risk factors for covid-19 symptom severity across clinical categories among hospitalised patients in kuala lumpur, malaysia: a prospective cohort study.  - bmj open.  1 - 13. 

     

    norsyafirah mohamed sallehuddin, mohd shahrir mohamed said, nik nuratiqah nik abeed, nor shuhaila shahril, noorul afidza muhammad, shiau li lim, andrea ban yu lin, boon hau ng, syahrul sazliyana shaharir.  (2025).  the prevalence and clinical profiling of rheumatoid arthritis associated interstitial lung disease (ra-ild) in a multicenter cohort.  - respirology.  183 - 184. 

     

    kelly sze fang num, azimatun noor aizuddin , syahnaz mohd hashim, mohd shahrir mohamed said .  (2025).  navigating interprofessional collaboration in diabetes care: a qualitative study of early-career health professionals in malaysian primary care clinics.  - plos one.  1 - 27. 

     

    syahrul sazliyana shaharir, azmawati mohammed nawi, theepa nesam mariamutu, lydia kamaruzaman, mohd shahrir mohamed said, sakthiswary rajalingham, ioannis parodis, manali sarkar, samuel katsuyuki shinjo, esha kadam, nelly ziade, chou luan tan, francis gullemin, carlo vincio caballero-uribe, ai lyn tan, laura andreoli1, jasmine parihar, praggya yaadav, sreoshy saha, covad study group, latika gupta, vikas agarwal.  (2025).  self-reported delayed adverse events and flare following covid-19 vaccination among patients with autoimmune rheumatic disease (aird) in malaysia: results from the covad-2 study.  - international journal of rheumatic diseases.  1 - 14. 

     

    yai wen choo, nurul ain mohd tahir, mohd shahrir mohamed said, mohd makmor bakry.  (2024).  health-related quality of life in osteoporosis: a systematic review of measurement properties of the qualeffo-41.  - osteoporosis international.  745-757. 

     

    farah aida a. zairol azwan, yi ying teo, nor asyikin mohd tahir, shamin mohd saffian, mohd makmor-bakry, mohd shahrir mohamed said.  (2024).  a systematic review of single nucleotide polymorphisms affecting allopurinol pharmacokinetics and serum uric acid level .  - pharmacogenomics.  479 - 494. 

     

    syahrul sazliyana s; cheng lay t ; chun ruh n ; asmahan m ;hairul hadi a ; anna farazilah m; asmah m ; siew houy c ;azwarina hanim ; chou luan t ; sharifah aishah w ; shakiras ; suhaida a ; eashwary m ; wan syamimee w ; hazlyna b ;nur farhana a ; sow lai k ; noraini m ; guo ruey l ; cheonhan g ; wan rosmaiza w; liza m; norliza z; mollyza m;habibah m; hashimah a ; siti mariam a ; syang pyng g ;mohd shahrir m.  (2024).  early lldas attainment and/or doris remission in a multi-ethnicmalaysian sle cohort: a multi-centre nationwide study.  - international journal of rheumatic diseases.  116 - 116. 

     

    fatimah zanirah nordin, syahrul sazliyana shaharir, mohd shahrir mohamed said, rozita mohd, rajalingham sakthiswary, tengku amatullah madeehah tengku mohd, mohd hafiz jaafar and wong chin yew.  (2024).  health seeking behaviour and diagnostic delays in sle: a multi-ethnic malaysian cohort study.  - lupus.  1645 - 1653. 

     

    chua siew huoy ; teh cheng lay ; shaharir syahrul sazliyana ; ng chun ruh ; mohamed ismail asmahan ; ariff hairul hadi ;mohd salleh anna farazillah ; mohd asmah; ramlan azwarina ; wan mohamad akbar sharifah aishah ; tan cl; selvananda shakira ; maulana suhaida ; mageswaren eashwary ; wan ghazali w ;baharuddin h ; abd manaf n ; kan s ; mat husin n ; ling g ;goh c ; wan musa w ; mohd isa l; shahril n ; zainuddin n;ch'ng s; mohd zain m; mohammed yusoof h; abu mansor matardiah h ; ab rahim s ; gan s ; mohamed said m ; mohd r .  (2024).  diversity in the initial manifestations of systemic lupus erythematosus (sle) in malaysia.  - international journal of rheumatic diseases.  79 - 80. 

     

    shantini radhakrishnan, salmi abdul razak, mohd shahrir mohamed said, noraida mohamed shah, adyani md redzuan.  (2022).  cardiovascular risks and primary interventions among treated rheumatoid arthritis patients: experience from a tertiary care centre in kuala lumpur, malaysia.  - tropical journal of pharmaceutical research.  863-870. 

     

    nor adzimah johdi , noraidatulakma abdullah , ying-xian goh, joanna ooi su min, nor azila muhammad azami , muhammad irfan abdul jalal , azmawati mohammed nawi, norfazilah ahmad , mohd rohaizat hassan, anita sulong, najma kori, petrick periyasamy, faisal hamid, norrafidah md sapuan, sheela bai pannir selvam, noriah hajib, norlaila mustafa, noor zetti zainol rashid, sharifah azura salleh, hamidah alias, mohd shahrir mohamed said, siti norlia othman, poh bee koon, faizal amri hamzah, shamsuriani md jamal, razman jarmin, hanita othman, khamsiah nawawi, hanafiah harunarashid, mohammad nizam mokhtar, wan rahiza wan mat, azwa shawani kamalul arifin, aisyatul najihah khuzaimi, nazihah abd jalal, norliza ismail, nurul ain mhd yusuf, andri dauni, wan ahmad faisal wan sallam, ahmad syafiq shafie, mohd arman kamaruddin, rahman jamal.  (2026).  risk factors for covid-19 symptom severity across clinical categories among hospitalised patients in kuala lumpur, malaysia: a prospective cohort study.  - bmj open.  1 - 13. 

     

    norsyafirah mohamed sallehuddin, mohd shahrir mohamed said, nik nuratiqah nik abeed, nor shuhaila shahril, noorul afidza muhammad, shiau li lim, andrea ban yu lin, boon hau ng, syahrul sazliyana shaharir.  (2025).  the prevalence and clinical profiling of rheumatoid arthritis associated interstitial lung disease (ra-ild) in a multicenter cohort.  - respirology.  183 - 184. 

     

    kelly sze fang num, azimatun noor aizuddin , syahnaz mohd hashim, mohd shahrir mohamed said .  (2025).  navigating interprofessional collaboration in diabetes care: a qualitative study of early-career health professionals in malaysian primary care clinics.  - plos one.  1 - 27. 

     

    syahrul sazliyana shaharir, azmawati mohammed nawi, theepa nesam mariamutu, lydia kamaruzaman, mohd shahrir mohamed said, sakthiswary rajalingham, ioannis parodis, manali sarkar, samuel katsuyuki shinjo, esha kadam, nelly ziade, chou luan tan, francis gullemin, carlo vincio caballero-uribe, ai lyn tan, laura andreoli1, jasmine parihar, praggya yaadav, sreoshy saha, covad study group, latika gupta, vikas agarwal.  (2025).  self-reported delayed adverse events and flare following covid-19 vaccination among patients with autoimmune rheumatic disease (aird) in malaysia: results from the covad-2 study.  - international journal of rheumatic diseases.  1 - 14. 

     

    thomas prisila, ping seung ong, mohd shahrir mohamed said, asrul abdul wahab.  (2025).  matrix metalloproteinase-9 as a biomarker for diagnosis and monitor disease progression in psoriatic arthritis.  - mediterranean journal of rheumatology.  380 - 386. 

     

    mohd dzulkhairi mohd rani, mohd shahrir mohamed said,ainoon othman, mohd khairul nizam zainan nazri.  (2012).  kebersihan diri.  - islam dan penjagaan kesihatan 1.  1 dan 17-27. 

     

    khairun nain nor aripin, che ilina che isahak, mohd shahrir mohamed said, noor fadzilah zulkifli, natasya abdullah, zairina abdul rahman, mohd dzulkhairi mohd rani, asral wirda ahmad asnawi, nazefah.  (2012).  pembangunan model farmasi halal dan program latihan untuk industri farmasi.  - 20 - 21. 

     

    mohd. shahrir m.s., low y.l., husni h., liew l.f., muhaini o..  (2012).  use of drugs for rheumatological and bone disorders.  - -. 

     

    nurulhuda mohd, badiah baharin, nik madihah nik azis, mohd shahrir mohamed said, hazla mohamed haflah, fazalina mohd fadzilah.  (2020).  periodontal disease in patients with rheumatoid arthritis and osteoarthritis: a cross sectional study.  - 1-2. 

     

    mohd shahrir mohamed said.  (2019).  rheumatologi ukm 20 tahun: ke arah penjagaan yang sempurna.  - syarahan perdana.  83. 

     

    mohd dzulkhairi mohd rani, mohd shahrir mohamed said,ainoon othman, mohd khairul nizam zainan nazri.  (2012).  kebersihan diri.  - islam dan penjagaan kesihatan 1.  1 dan 17-27. 

     

    khairun nain nor aripin, che ilina che isahak, mohd shahrir mohamed said, noor fadzilah zulkifli, natasya abdullah, zairina abdul rahman, mohd dzulkhairi mohd rani, asral wirda ahmad asnawi, nazefah.  (2012).  pembangunan model farmasi halal dan program latihan untuk industri farmasi.  - 20 - 21. 

     

    farah aida a. zairol azwan, shamin mohd saffian, mohd makmor-bakry, mohd shahrir mohamed said, nor asyikin mohd tahir.  (2025).  the influence of abcg2 rs2231142 and haox1 rs3731722 polymorphisms on oxypurinol concentration in gout patients.  - regional asia-pacific therapeutic drug monitoring conference 2025 (raptdm2025). 

     

    farah aida a. zairol azwan, shamin mohd saffian, mohd makmor-bakry, mohd shahrir mohamed said, nor asyikin mohd tahir.  (2025).  population pharmacokinetic of oxypurinol in adult patients: a systematic review.  - regional asia-pacific therapeutic drug monitoring conference 2025 (raptdm2025). 

     

    teo yi ying, farah aida a. zairol azwan, shamin saffian, mohd makmor-bakry, mohd shahrir mohamed said, nor asyikin mohd tahir..  (2024).  effects of single nucleotide polymorphism (snp) in pharmacokinetic (pk) of allopurinol and oxypurinol: a scoping review.  - 2nd pharmcare symposium. 

     

    mohd shahrir bin mohamed said;rahana binti abd rahman;shamsul azhar bin shah;elena aisha binti azizan.  (2024).  obstetric antiphospholipid syndrome (oaps): a multicenter pilot study of the association between antiphospholipid antibodies and genetic biomarker of the targeted genotypes to the adverse pregnancy outcomes in malaysian oaps patients”.  -

     

    muhammad asyraf jamaluddin, rizuana iqbal hussain, chin kok yong, mohd shahrir mohamed said.  (2023).  correlation between covid-19 and pulmonary thromboembolism on ct pulmonary angiography in adult population - a scoping review.  - the 79th korean society of radiology (kcr 2023).  633. 

     
    Geran / Grant Kolaborator / Collaborator Status
    A MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, ACTIVE-CONTROLLED, THERAPEUTIC CONFIRMATORY, PHASE III STUDY TO COMPARE AND EVALUATE THE EFFICACY AND SAFETY OF EPAMINURAD WITH FEBUXOSTAT IN GOUT PATIENTS. fortrea malaysia sdn. bhd.
    72.3% (2023-12-21 sehingga 2027-01-20)
    A PHASE 2A, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF MK-6194 IN ADULT PARTICIPANTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS merck sharp & dohme (malaysia) sdn. bhd.
    56.3% (2024-03-25 sehingga 2027-09-24)
    A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF CENERIMOD IN ADULT SUBJECTS WITH MODERATE-TO-SEVERE SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) ON TOP OF BACKGROUND TH novotech clinical research (malaysia) sdn. bhd.
    69.4% (2024-12-26 sehingga 2026-09-25)
    A RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, PLACEBO-CONTROLLED MULTICENTER STUDY TO EVALUATE EFFICACY, SAFETY AND TOLERABILITY OF IANALUMAB IN PARTICIPANTS WITH DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS novartis corporation (malaysia) sdn. bhd.
    15.5% (2025-04-17 sehingga 2031-02-16)
    THE EUROPEAN ALLIANCE OF ASSOCIATIONS FOR RHEUMATOLOGY/AMERICAN COLLEGE OF RHEUMATOLOGY (EULAR/ACR) CLASSIFICATION CRITERIA FOR SYSTEMIC LUPUS ERYTHEMATOSUS: A VALIDATION STUDY OF AN ASIA PACIFIC COHORT OF PATIENTS asia pacific league associations for rheumatology (aplar)
    8.1% (2026-01-29 sehingga 2027-07-28)

    CLINICAL MEDICAL :CLINICAL AND HEALTH SCIENCES
    Rheumatology
    Pengalaman / Experience : tahun/years(s)

    HEALTH SCIENCES :CLINICAL AND HEALTH SCIENCES
    General Rheumatology
    Pengalaman / Experience : 11 tahun/years(s)